Govt encourages vaccine production by public sector enterprises

Vaccine manufacturing in the public sector units has been resumed and the central government is taking steps to ensure their contribution in supplying key pentavalent vaccines


The vaccine production by PSUs has always been surrounded by controversies on quality and inability to produce as per required quantities from time to time.

The union government has approved the establishment of an Integrated Vaccine Complex, Chengalpattu, Tamil Nadu as a subsidiary of HLL Lifecare, a Central Public Sector Enterprise, which will produce Pentavalent Vaccines - Hepatitis B, HiB, Measles, Anti Rabies, BCG, and Japanese Encephalitis vaccines.

As per the union health minister, Dr Harsh Vardhan, "The government has also approved the upgradation and setting-up of new Good Manufacturing Practices (cGMP) complaint facilities for increasing vaccine productions in the other three vaccine producing units namely Pasteur Institute of India, Coonoor; Central Research Institute, Kasauli and BCG Vaccine Laboratory, Guindy under the ministry of health and family welfare.

The government on February, 02, 2010 had revoked suspension of manufacturing licenses of all the three vaccine-manufacturing units, pending setting up of Good Manufacturing Practices (cGMP) complaint production facilities. All the three manufacturing units have already resumed production of vaccines in the existing facilities.


1 Comment Comment 1 - 1 of 1

Presith Prakash 25 July 2014 at 05:05 PM

Valid Article


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email